{"title":"Glioblastoma-associated microglia/macrophages (GAMs): Advances in knowledge and implications for glioblastoma (GBM) therapy","authors":"Siddhartha Singh, Rashmi Mishra","doi":"10.1016/j.bbcan.2026.189742","DOIUrl":"10.1016/j.bbcan.2026.189742","url":null,"abstract":"<div><div>Glioblastoma (GBM) is an exceptionally aggressive, therapy-resistant central nervous system malignancy. Within the tumour microenvironment, glioblastoma-associated microglia and macrophages (GAMs) constitute a highly heterogeneous population whose functional states profoundly influence disease progression, tissue architecture, immune evasion, and treatment response. In this review, we propose a conceptual framework in which distinct GAM phenotypes emerge from the integrated influence of vascular, tumoural, metabolic, biomechanical, neural, and immune inputs, together with glyco-immune interactions, extracellular vesicles, and epigenetic regulation. As GAMs process these cues, they actively remodel their surrounding ecosystem, sustaining a protumourigenic niche. We critically evaluate emerging therapeutic interventions-including those targeting GAM abundance, immunometabolism, mechanotransduction, and intercellular communication-as well as advanced platforms such as engineered myeloid systems, phytomedicines, targeted delivery vehicles, and gut-brain axis-based strategies. Furthermore, we address key translational bottlenecks, including extreme GAM plasticity, spatial heterogeneity, limitations of preclinical models, barriers to central nervous system delivery, and a lack of predictive biomarkers. We argue that the therapeutically relevant target is not the GAM population in isolation, but rather the diverse niche-GAM functional units and the cumulative signalling networks that sustain them. Ultimately, achieving durable clinical efficacy will require biomarker-guided, spatially informed combination regimens that selectively disrupt maladaptive myeloid states while preserving physiological microglial homeostasis.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 6","pages":"Article 189742"},"PeriodicalIF":11.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rosita Curcio, Eugenia Nicol Manti, Federico Di Cocco, Simone Scagnoli, Grazia Chiellini, Bruna Cerbelli, Cristian Scatena, Marco Fiorillo
{"title":"Lipid metabolism in cancer cells: implications and roles in ferroptosis","authors":"Rosita Curcio, Eugenia Nicol Manti, Federico Di Cocco, Simone Scagnoli, Grazia Chiellini, Bruna Cerbelli, Cristian Scatena, Marco Fiorillo","doi":"10.1016/j.bbcan.2026.189749","DOIUrl":"10.1016/j.bbcan.2026.189749","url":null,"abstract":"<div><div>Lipid metabolism is extensively reprogrammed in cancer to support tumor growth, survival, metastasis, and therapeutic adaptation. Among these metabolic alterations, cholesterol metabolism has emerged as a central regulator of cellular homeostasis, extending well beyond its classical structural role in biological membranes. Increasing evidence indicates that sterol metabolism influences ferroptosis, an iron-dependent form of regulated cell death driven by phospholipid peroxidation, through multiple interconnected mechanisms involving membrane organization, redox homeostasis, and metabolic adaptation.</div><div>In this review, we provide an integrated overview of the cholesterol-ferroptosis axis by organizing current evidence into three complementary regulatory strata. The biophysical stratum encompasses the role of cholesterol and membrane organization in modulating lipid packing, membrane architecture, and susceptibility to lipid peroxidation. The metabolic stratum focuses on the contribution of the mevalonate pathway to ferroptosis defense through glutathione peroxidase 4, ferroptosis suppressor protein 1, dihydroorotate dehydrogenase, and GTP cyclohydrolase 1/tetrahydrobiopterin-dependent antioxidant systems, as well as the emerging roles of sterol intermediates such as squalene and 7-dehydrocholesterol. The signaling and microenvironmental stratum highlights how oncogenic pathways together with hypoxia, nutrient limitation, extracellular acidosis, and other tumor microenvironmental pressures reshape cholesterol metabolism and influence ferroptosis sensitivity.</div><div>We further discuss several unresolved biological paradoxes, including the dual effects of cholesterol accumulation on membrane protection and lipotoxicity, the context-dependent consequences of mevalonate pathway inhibition, and the remarkable metabolic plasticity that limits the efficacy of cholesterol-targeting therapies. Finally, we discuss emerging therapeutic opportunities based on mechanism-driven combination strategies and emphasize the need to integrate genomic, lipidomic, and metabolic profiling to identify context-dependent vulnerabilities within the sterol–ferroptosis network. Collectively, this framework highlights cholesterol metabolism as a dynamic regulator of ferroptosis and provides a conceptual basis for the development of more precise therapeutic approaches targeting metabolic adaptation in cancer.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 6","pages":"Article 189749"},"PeriodicalIF":11.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Caini Lan, Xiao Yang, Fei Wang, Chao Wan, Kunyu Yang
{"title":"Co-opted immune homeostatic restraint in cancer: Mechanisms of immunosuppression and implications for immunotherapy resistance","authors":"Caini Lan, Xiao Yang, Fei Wang, Chao Wan, Kunyu Yang","doi":"10.1016/j.bbcan.2026.189744","DOIUrl":"10.1016/j.bbcan.2026.189744","url":null,"abstract":"<div><div>Tumors can exploit physiological mechanisms of immune restraint and tissue repair to sustain immunosuppression and limit responses to immunotherapy. This review connects physiological immune regulation with tumor immune escape across checkpoint signaling, metabolism, suppressive immune-cell populations and tissue remodeling. We distinguish activation-coupled negative feedback, persistent deployment of homeostatic or repair programs, and additional tumor-associated suppressive programs, including self-reinforcing circuits. These forms of regulation can coexist and involve shared molecules, but differ in their initiating signals and dependence on continued stimulation or cellular interactions. We examine the evidence linking physiological functions to their altered deployment in cancer and distinguish pre-existing suppression, changes induced during treatment and mechanisms of acquired resistance. We then assess therapeutic strategies according to their experimental and clinical support, including unsuccessful approaches, and discuss how spatial and longitudinal measurements can inform biomarker development and trial design. By linking physiological functions to the processes sustaining suppression, this framework provides a mechanistic basis for classifying immunosuppressive programs. It may guide the selection and timing of therapeutic combinations to achieve more durable antitumor responses.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 6","pages":"Article 189744"},"PeriodicalIF":11.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cellular senescence remodels the neuro-immune-tumour niche in neuroblastoma through SASP and core signalling pathways","authors":"Zhihan Zhang, Xiaoling Zhang","doi":"10.1016/j.bbcan.2026.189750","DOIUrl":"10.1016/j.bbcan.2026.189750","url":null,"abstract":"<div><div>Neuroblastoma (NB), the most common extracranial solid tumour in children, presents a stark clinical dichotomy: stage 4S disease may spontaneously regress, whereas high-risk patients face persistently high relapse and mortality rates despite intensive therapy. This suggests that the tumour microenvironment (TME) critically governs disease trajectory. Cellular senescence, a stress-responsive cell fate, has been increasingly implicated in NB, yet its dual pro- and anti-tumourigenic roles remain unclear. Senescence is not uniform; rather, distinct induction conditions generate divergent senescence-associated secretory phenotypes (SASPs), which exert context-dependent paracrine effects on neural, immune, and tumour cells within the TME. This review examines how senescence-driven SASP may remodel the neuro-immune-tumour microenvironment. We outline the triggers and cellular origins of senescence, characterize SASP composition and transcriptional control, and describe its potential multifaceted effects on immune reprogramming, neuroinflammation, and tumour progression. Integrating PI3K/Akt/mTOR and autophagy-apoptosis signalling, along with adjacent neurogenic signals such as SP/NK-1R, we hypothesize that the contrasting outcomes of 4S versus high-risk disease reflect alternative fate switches among senescence, autophagy, and apoptosis. We also summarize emerging senolytic, senomorphic, and neuroimmune-targeted strategies, along with their clinical prospects. A deeper understanding of senescence heterogeneity in neuroblastoma may offer both biological insights and new therapeutic avenues.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 6","pages":"Article 189750"},"PeriodicalIF":11.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149336421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fernando Martínez-Cortés, Jesus Guzman Valle, Jorge Maruri, Braulio A. Martínez-Zarco, Allan Noé Domínguez-Romero, Goar Gevorkian, Karen Manoutcharian
{"title":"Neoantigen evolution in cancer: immunoediting, immune escape, and future vaccine strategies","authors":"Fernando Martínez-Cortés, Jesus Guzman Valle, Jorge Maruri, Braulio A. Martínez-Zarco, Allan Noé Domínguez-Romero, Goar Gevorkian, Karen Manoutcharian","doi":"10.1016/j.bbcan.2026.189741","DOIUrl":"10.1016/j.bbcan.2026.189741","url":null,"abstract":"<div><div>Cancer immunotherapy has changed cancer treatment, with neoantigen-based vaccines emerging as a promising strategy to induce tumor-specific immune responses while minimizing adverse effects on healthy tissues. Advances in next-generation sequencing, immunopeptidomics, artificial intelligence, and computational prediction have accelerated the identification of patient-specific neoantigens and enabled the development of personalized cancer vaccines. Despite encouraging safety profiles and robust induction of neoantigen-specific T-cell responses, clinical efficacy has remained inconsistent. Tumor evolution driven by genomic instability continuously reshapes the neoantigen landscape through intratumoral heterogeneity, immune-mediated selection, and antigen gain or loss, facilitating immune escape and limiting durable therapeutic responses. In addition, T-cell dysfunction and the immunosuppressive tumor microenvironment further compromise vaccine efficacy. In this review, we discuss the origin and diversity of tumor antigens, recent advances in neoantigen identification and vaccine development, and the biological mechanisms that constrain the clinical success of personalized cancer vaccines. We summarize evidence from clinical trials that highlights both the promise and the current limitations of neoantigen-based immunotherapy, and discuss the importance of incorporating tumor evolution into vaccine design. Finally, we present Variable Epitope Libraries (VELs), a vaccine strategy that uses immunogens based on combinatorial libraries of highly mutated epitope variants designed to broaden immune recognition, reduce immune escape, and improve the durability and effectiveness of cancer immunotherapy.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 6","pages":"Article 189741"},"PeriodicalIF":11.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149302979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xin Zhao, Zhuoran Liu, Jie Yang, Kangyi Jiang, Fengwei Gao
{"title":"Reframing perineural invasion in intrahepatic cholangiocarcinoma as a spatial neuroimmune niche","authors":"Xin Zhao, Zhuoran Liu, Jie Yang, Kangyi Jiang, Fengwei Gao","doi":"10.1016/j.bbcan.2026.189747","DOIUrl":"10.1016/j.bbcan.2026.189747","url":null,"abstract":"<div><div>Perineural invasion (PNI) is an adverse histopathological feature in intrahepatic cholangiocarcinoma (iCCA), yet its biological meaning is often reduced to a binary pathology variable. This convention overlooks the spatial heterogeneity of the tumour–nerve interface, where nerve subtype, tumour–nerve geometry, stromal organization and immune-cell positioning may carry distinct clinical implications. Recent iCCA-specific evidence identifies, in selected PNI-positive tumours, TH-positive sympathetic fibres, increased norepinephrine, tumour-cell ADRB2–PI3K–AKT–NF-κB–MDK signalling and ferroptosis-associated dysfunction of CD56dimCD16+ natural killer cells. This is currently the strongest disease-specific neuroimmune axis, but it represents only one component of a broader niche that may include CD8+ T-cell exclusion or exhaustion, regulatory and helper T-cell states, macrophage/MDSC suppression, CAF/ECM barriers and TLS topology. In this Review, we distinguish direct iCCA or iCCA-PNI evidence from evidence from other CCA subtypes or general iCCA studies and from cross-cancer hypotheses. We propose a candidate, unvalidated spatial neuroimmune framework that integrates neural phenotyping, spatial immune mapping and imaging. The framework is intended to support four separate research uses—prognostic stratification, preoperative prediction of pathological PNI, pharmacodynamic monitoring and prospective treatment-benefit testing—and should not be treated as a validated clinical score or as a basis for unselected neural or immune therapy. This approach may move PNI reporting from a binary risk label toward a testable, spatially resolved model of iCCA heterogeneity.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 6","pages":"Article 189747"},"PeriodicalIF":11.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lorenzo Mainardi, Narendhar Gokulanathan, Chiara Raggi, Venkata Pradeep Babu Koyyala
{"title":"Gallbladder cancer beyond genetics: tumor–immune microenvironment interactions and emerging translational therapeutic strategies","authors":"Lorenzo Mainardi, Narendhar Gokulanathan, Chiara Raggi, Venkata Pradeep Babu Koyyala","doi":"10.1016/j.bbcan.2026.189740","DOIUrl":"10.1016/j.bbcan.2026.189740","url":null,"abstract":"<div><div>Gallbladder cancer (GBC) is an aggressive malignancy where tumor-intrinsic genomic alterations fail to fully explain its rapid invasiveness and therapeutic resistance. Unlike more generic reviews focused broadly on biliary tract cancers or limited to isolated genomic profiling, this review provides an in-depth dissection of the GBC tumor microenvironment (TME) as an integrated tumor–immune–stromal–neural ecosystem. Key microenvironmental drivers are illuminated, including cancer-associated fibroblast remodeling, immunosuppressive myeloid reprogramming, T-cell dysfunction, and neuro-tumor crosstalk driving perineural invasion. Crucially, this review establishes a structured evidence hierarchy that rigorously distinguishes GBC-specific findings from broader biliary cohorts and tumor-agnostic data. By synthesizing multimodal computational frameworks and microenvironment-directed combination strategies, this review provides an actionable precision oncology roadmap to overcome therapeutic resistance and improve patient outcomes in GBC.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 6","pages":"Article 189740"},"PeriodicalIF":11.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149278485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Glioblastoma under chemotherapy pressure: interconnected tumor-cell adaptations shaping tumor behaviour and resistance","authors":"Paola Palumbo","doi":"10.1016/j.bbcan.2026.189746","DOIUrl":"10.1016/j.bbcan.2026.189746","url":null,"abstract":"<div><div>Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and remains largely incurable because of its marked cellular heterogeneity, limited drug delivery, and rapid development of resistance to temozolomide (TMZ). Beyond its cytotoxic activity, TMZ induces genotoxic and oxidative stress and exerts strong selective pressure, potentially promoting adaptive states in GBM cells that survive chemotherapy. These adaptive responses are heterogeneous and context-dependent and may not only promote tumor cell intrinsic resistance but also strongly reshape the surrounding tumor microenvironment.</div><div>This review focuses on residual tumor cells that survive TMZ-induced stress and examines how their adaptive responses contribute to treatment resistance and may be sustained by reciprocal interactions with the tumor microenvironment. Specifically, it integrates findings on stem-like enrichment, inflammatory and redox signalling, altered extracellular vesicle release, therapy-induced senescence, and extracellular matrix remodelling, examining how these processes may reinforce one another and link tumor cell survival to signals that influence neighbouring malignant and non-malignant cells. Findings are interpreted within their experimental context, distinguishing evidence from <em>in vitro</em> studies, animal models, and patient samples.</div><div>This integrated framework provides a rationale for investigating TMZ-based strategies aimed not only at eliminating surviving GBM cells but also at limiting their ability to promote a microenvironment that supports tumor persistence and resistance.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 6","pages":"Article 189746"},"PeriodicalIF":11.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149328534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jing Ma , Sally K.Y. To , Xinyu Zhang , Weiyang Zhao , Peng Zhang , Alice S.T. Wong
{"title":"Emerging perspectives on metabolic reprogramming in the microenvironment of ovarian cancer metastasis","authors":"Jing Ma , Sally K.Y. To , Xinyu Zhang , Weiyang Zhao , Peng Zhang , Alice S.T. Wong","doi":"10.1016/j.bbcan.2026.189554","DOIUrl":"10.1016/j.bbcan.2026.189554","url":null,"abstract":"<div><div>Ovarian cancer (OC) is one of the most lethal malignancies in females, mainly due to the aggressive metastasis at the late stage and the unsatisfactory of current therapies. OC cells exhibit a special metastatic behavior compared to other common epithelial tumors, primarily spreading within the peritoneal cavity. Due to the complexity of tumor microenvironment, physical factors induce significant metabolic changes in OC cells, thereby enhancing their metastatic ability. Key cellular components, such as cancer-associated fibroblasts and adipocytes, act synergistically to support metastasis through metabolic interactions. Recent efforts in tumor immunometabolism showed that metabolic reprogramming of immune cells can also significantly impact metastatic progression. Moreover, the microbiome and cellular senescence are emerging as important factors that alter the metabolic landscape. This review provides a systematic review of metabolic reprogramming in the OC microenvironment and highlights the most recent clinical trials targeting metabolic pathways. By increasing our understanding of these metabolic interactions, we can develop innovative metabolism-targeting interventions for this devastating gynecological malignancy.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 2","pages":"Article 189554"},"PeriodicalIF":9.7,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146168431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The interplay between cytokines and immune checkpoints in breast cancer therapy","authors":"Ying Wu , Yin Zhu , Qing Cang , Zakari Shaibu , Lifeng Kong , Qi Zhou , Xinxin Li , Liang Yin","doi":"10.1016/j.bbcan.2026.189539","DOIUrl":"10.1016/j.bbcan.2026.189539","url":null,"abstract":"<div><div>Breast cancer (BC) immunotherapy has transformed treatment paradigms, yet response rates remain limited by the complex interplay between cytokine networks and immune checkpoints. This review synthesizes emerging evidence on how cytokines dynamically regulate immune checkpoint expression and function within the breast tumor microenvironment. We examine pro-tumorigenic cytokine circuits alongside immunostimulatory pathways. A key focus is the subtype-specific nature of these interactions, with triple-negative breast cancers (TNBC) exhibiting distinct cytokine-checkpoint crosstalk compared to hormone receptor-positive subtypes. The review highlights innovative therapeutic strategies, including cytokine-targeting agents in clinical trials and engineered approaches like spatial-targeted nanocarriers. We further discuss how cutting-edge technologies from single-cell RNA sequencing to spatial proteomics are revealing novel biomarker opportunities. By decoding these intricate immune dialogues, this review provides a framework for developing precision immunotherapy combinations tailored to BC immunological heterogeneity.</div></div>","PeriodicalId":8782,"journal":{"name":"Biochimica et biophysica acta. Reviews on cancer","volume":"1881 2","pages":"Article 189539"},"PeriodicalIF":9.7,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146042290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}